Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Disanto

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Expert Opinion on Biological Therapy|April 5, 2015
Natalizumab in spinal multiple sclerosis in a daily clinical settingChiara Zecca, Mirjam R Heldner, Christian P Kamm, et al.
European Journal of Neurology|June 18, 2021
Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parametersGianna C Riccitelli, Giulio Disanto, Rosaria Sacco, et al.
Journal of Clinical Medicine|February 3, 2021
Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple SclerosisCamilla Ostini, Francesca Bovis, Giulio Disanto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 16, 2015
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribineJulia Pakpoor, Giulio Disanto, Daniel R Altmann, et al.
Diagnostic and Prognostic Research|October 28, 2021
Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosisKonstantina Chalkou, Ewout Steyerberg, Patrick Bossuyt, et al.
Frontiers in Neuroimaging|November 20, 2025
Fully-automated estimation of upper cervical cord cross-sectional area using pontomedullary junction referencing in multiple sclerosisRoberto Masciullo, Annine Sutter, Rosaria Sacco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2023
Interplay between age and disease-modifying treatments in influencing infection risk in multiple sclerosisSarah Lena Susanna Jacober, Giulio Disanto, Rosaria Sacco, et al.
Neurology|March 27, 2015
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosisJens Kuhle, Giulio Disanto, Johannes Lorscheider, et al.
Journal of Neuroimmunology|May 12, 2009
Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian familiesSreeram V Ramagopalan, Katie M Morrison, Andrea Para, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2022
Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 YearGiulio Disanto, Alice Galante, Marco Cantu', et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Expert Opinion on Biological Therapy|April 5, 2015
Natalizumab in spinal multiple sclerosis in a daily clinical settingChiara Zecca, Mirjam R Heldner, Christian P Kamm, et al.
European Journal of Neurology|June 18, 2021
Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parametersGianna C Riccitelli, Giulio Disanto, Rosaria Sacco, et al.
Journal of Clinical Medicine|February 3, 2021
Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple SclerosisCamilla Ostini, Francesca Bovis, Giulio Disanto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 16, 2015
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribineJulia Pakpoor, Giulio Disanto, Daniel R Altmann, et al.
Diagnostic and Prognostic Research|October 28, 2021
Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosisKonstantina Chalkou, Ewout Steyerberg, Patrick Bossuyt, et al.
Frontiers in Neuroimaging|November 20, 2025
Fully-automated estimation of upper cervical cord cross-sectional area using pontomedullary junction referencing in multiple sclerosisRoberto Masciullo, Annine Sutter, Rosaria Sacco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2023
Interplay between age and disease-modifying treatments in influencing infection risk in multiple sclerosisSarah Lena Susanna Jacober, Giulio Disanto, Rosaria Sacco, et al.
Neurology|March 27, 2015
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosisJens Kuhle, Giulio Disanto, Johannes Lorscheider, et al.
Journal of Neuroimmunology|May 12, 2009
Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian familiesSreeram V Ramagopalan, Katie M Morrison, Andrea Para, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2022
Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 YearGiulio Disanto, Alice Galante, Marco Cantu', et al.
Pageof 13